ACCURUN® 342 Series 100 Chlamydia trachomatis Neisseria gonorrhea Nucleic Acid Positive Control | 2025-0067

ACCURUN® 342 Series 100 Chlamydia trachomatis Neisseria gonorrhea Nucleic Acid Positive Control Cat# 2025-0067 from Seracare is available for UK & Europe Delivery.

ACCURUN 342 Series 100 is formulated for use with in vitro test procedures that detect Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid. ACCURUN 342 Nucleic Acid Positive Control Series 100 is prepared by diluting elementary bodies derived from cultured Chlamydia trachomatis and cultured Neisseria gonorrhoeae in a buffer simulating specimen transport media. The control contains whole cell organisms simulating a naturally occurring sample.The control is “ready to use“ in assays that detect Chlamydia trachomatis and Neisseria gonorrhea.

ACCURUN 342

• Can help you to monitor your Ct/Ng DNA assay with a reliable source of positive material;
• Provides additional confidence in your lab’s test results.
• Analytes included: Chlamydia trachomatis and Neisseria gonorrhoea

ACCURUN Molecular controls are relied upon by many world-class laboratories to ensure assay performance. For in vitro diagnostic use. Regulatory Status: IVD, CE.